Cargando…
Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model
Osteosarcoma is the most prevalent primary bone malignancy in children and adolescents. Neoadjuvant chemotherapy combined with surgical resection, the current standard treatment of osteosarcoma, is associated with a 5-year survival rate of only ~70%. Therefore, it is necessary to identify new, more...
Autores principales: | Luo, Xuwen, Liu, Xuqiang, Tao, Qianyuan, Yao, Cong, Wang, Fuqiang, Gu, Zhiping, Li, Feilong, Yu, Xiaolong, Zhang, Bin, Fan, Hongxian, Dai, Min, Nie, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377056/ https://www.ncbi.nlm.nih.gov/pubmed/32724382 http://dx.doi.org/10.3892/ol.2020.11656 |
Ejemplares similares
-
Comparison between minimally invasive plate osteosynthesis and open reduction-internal fixation for proximal humeral fractures: a meta-analysis based on 1050 individuals
por: Li, Feilong, et al.
Publicado: (2019) -
A Bone-Targeting Enoxacin Delivery System to Eradicate Staphylococcus Aureus-Related Implantation Infections and Bone Loss
por: Yao, Cong, et al.
Publicado: (2021) -
The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats
por: Liu, Xuqiang, et al.
Publicado: (2017) -
Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis
por: Vracar, Taylor C., et al.
Publicado: (2018) -
Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment
por: Xu, Qiang, et al.
Publicado: (2021)